Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance

European Journal of Pharmacology

Volumn 389, Issue 1, 2000, Pages 71-78

  Puisieux, François ^a   Deplanque, Dominique ^a   Pu, Qian ^a   Souil, Evelyne ^b   Bastide, Michèle ^a   Bordet, R égis ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

(Rat); Brain; Cerebral ischemia; Heat shock protein; Ischemic tolerance; Lipopolysaccharide; Nitric oxide (NO); Nitric oxide synthase (NOS); Nitro L arginine methyl ester; Preconditioning

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; HEAT SHOCK PROTEIN 70; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0034635407     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00893-6     Document Type: Article

References (32)

1. Abe H., Nowak T.S. Gene expression and induced ischemic tolerance following brief insults. Acta Neurobiol. Exp. 56:1996;3-8.
2. Bachelet M., Mariéthoz E., Banzet N., Souil E., Pinot F., Polla C.Z., Durand P., Bouchaert I., Polla B.S. Flow cytometry is a rapid and reliable method for evaluating heat shock protein 70 expression in human monocytes. Cell Stress Chaperones. 1998:1998;168-176.
3. Barone F.C., White R.F., Spera P.A., Ellison J., Currie R.W., Wang X., Feuerstein G.Z. Ischemic preconditioning and brain tolerance. Temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 29:1998;1937-1951.
4. Bastide M., Bordet R., Pu Q., Robin E., Puisieux F., Dupuis B. Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 19:1999;1309-1315.
5. Baxter G.F., Goodwin R.W., Wright M.J., Kerac M., Heads R.J., Yellon D.M. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Br. J. Pharmacol. 117:1996;1685-1692.
6. Bolli R., Bhatti Z.A., Tang X.-L., Qiu Y., Zhang Q., Guo Y., Jadoon A.K. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ. Res. 81:1997;42-52.
7. Centeno J.M., Orti M., Salom J.B., Sick T.J., Perez-Pinzon M.A. Nitric oxide is involved in anoxic preconditioning neuroprotection in rat hippocampal slices. Brain Res. 836:1999;62-69.
8. Chen J., Graham S.H., Zhu R.L., Simon R.P. Stress proteins and tolerance to focal ischemia. J. Cereb. Blood Flow Metab. 16:1996;566-577.
9. Chen J., Simon R. Ischemic tolerance in the brain. Neurology. 48:1997;306-311.
10. Dawson D.A., Furuya K., Gotoh J., Nakao Y., Hallenbeck J.M. Cerebrovascular hemodynamics and ischemic tolerance: lipopolysaccharide-induced resistance to focal cerebral ischemia is not due to changes in severity of the initial ischemic insult, but is associated with preservation of microvascular perfusion. J. Cereb. Blood Flow Metab. 19:1999;616-623.
11. Glazier S.S., O'Rourke D.M., Graham D.I., Welsh F.A. Induction of ischemic tolerance following brief focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 14:1994;545-553.
12. + channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4666-4670.
13. Huang K.T., Kuo L., Liao J.C. Lipopolysaccharide activates endothelial nitric oxide synthase through protein tyrosine kinase. Biochem. Biophys. Res. Commun. 245:1998;33-37.
14. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
15. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K., Kamada T. Ischemic tolerance phenomenon found in the brain. Brain Res. 528:1990;21-24.
16. Kobayashi S., Harris V.A., Welsh F.A. Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow Metab. 15:1995;721-727.
17. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
18. Maulik N., Tosaki A., Elliott G.T., Maulik G., Das D.K. Induction of iNOS gene expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia. Drugs Exp. Clin. Res. 24:1998;117-124.
19. McKenna T.M., Li S., Tao S. PKC mediates LPS and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am. J. Physiol. 269:1995;H1891-H1898.
20. Nakata N., Kato H., Kogure K. Inhibition of ischaemic tolerance in the gerbil hippocampus by quetercin and anti-heat shock protein-70 antibody. NeuroReport. 4:1993;695-698.
21. Nayeem M.A., Elliott G.T., Shah M.R., Hastillo-Hess S.L., Kukreja R.C. Monophosphoryl lipid A protects adult rat cardiac myocytes with induction of the 72 kD heat shock protein: a cellular model of pharmacologic preconditioning. J. Mol. Cell. Cardiol. 29:1997;2305-2310.
22. Okamoto H., Roman R.J., Kampine J.P., Hudetz A.G. Expression of inducible isoforms of nitric oxide synthase and cyclooxigenase plays an important role in endotoxin-induced cerebral hyperhemia in rats. J. Cereb. Blood Flow Metab. 17(Suppl 1):1997;S406.
23. Pu Q., Bordet R., Robin E., Puisieux F., Vallet B., Dupuis B. Low dose of lipopolysaccharide induces a delayed enhanced nitric oxide-mediated relaxation in rat aorta. Eur. J. Pharmacol. 377:1999;209-214.
24. Qiu Y., Rizvi A., Tang X.L., Manchikalapudi S., Takano H., Jadoon A.K., Wu W.J., Bolli R. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am. J. Physiol. 273:1997;H2931-H2936.
25. Rokutan K., Hirakawa T., Teshima S., Nakano Y., Miyoshi M., Kawai T., Konda E., Morinaga H., Nikawa T., Kishi K. Implications of heat shock/stress proteins for medicine and disease. J. Med. Invest. 44:1998;137-147.
26. 2+-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
27. Shindo T., Ikeda U., Ohkawa F., Kawahara Y., Yokoyama M., Shimada K. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc. Res. 29:1995;813-819.
28. Stoclet J.C., Muller B., Andriantsitohaina R., Kteschyou A. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry (Moscow). 63:1998;826-832.
29. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharid pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748:1997;267-270.
30. Van Dam A.M., Bauer J., Man-A-Hing W.K., Marquette C., Tilders F.J., Berkenbosch F. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40:1995;251-260.
31. Yoshida K., Maaieh M.M., Shipley J.B., Doloresco M., Bernardo N.L., Qian Y.Z., Elliott G.T., Kukreja R.C. Monophosphoryl lipid A induces pharmacologic `preconditioning' in rabbit hearts without concomitant expression of 70 kDa heat shock protein. Mol. Cell. Biochem. 159:1996;73-80.
32. Zhao L., Weber P.A., Smith J.R., Comerford M.L., Elliott G.T. Role of inducible nitric oxide synthase in pharmacological «preconditioning» with monophosphoryl lipid A. J. Mol. Cell. Cardiol. 29:1997;1567-1576.